KCTD15 (NM_024076) Human Untagged Clone

CAT#: SC319396

KCTD15 (untagged)-Human potassium channel tetramerisation domain containing 15 (KCTD15), transcript variant 1

Specifications

Product Data

• Type: Human Untagged Clone
• Tag: Tag Free
• Symbol: KCTD15
• Vector: pCMV6-AC
• E. coli Selection: Ampicillin (100 ug/mL)
• Mammalian Cell Selection: Neomycin
• Sequence Data:
  Fully Sequenced ORF

  >OriGene sequence for NM_024076.1 GTAACTCCAGGACGAGACCGGAGCGACCCGCGCAGCGAGCATAGGCGGCGAAGCTGCGCC
  CGGCGCCCGAGACCGGCAGCTGCGTGGGGCGGGGGCTGCGCCCGAGCCCGATCTGCCGGC
  TCCGAGCAGTGGTCTCGGAAAGAGGGTCGTGGTCCCGCACGGATGCGCTTGTTGGGAGAA
  ACCTTGGAGATTCACGGCAAGGCGTAAAGCCTGGGGCTTCCAACGATACTCTGGGCAGGG
  ATGGAAGCCTAGATGCCTCACCGCAAGGAGCGGCCGAGCGGGTCCTCGCTTCACACACAC
  GGCAGCACCGGCACCGCGGAGGGAGGAAACATGTCCCGGCTGTCTCTCACCCGGTCGCCT
  GTGTCTCCCCTGGCTGCCCAGGGCATCCCCCTGCCAGCCCAGCTCACCAAGTCCAATGCA
  CCTGTGCACATCGATGTGGGCAGCCACATGTACACCAGCAGCCTGGCCACGCTCACCAAG
  TACCCTGACTCCAGGATAAGCCGCCTCTTCAATGGCACTGAACCCATCGTCCTGGACAGT
  TTGAAGCAACATTATTTCATTGACCGGGATGGGGAGATTTTCCGCTACGTCCTGAGCTTC
  CTGCGGACGTCCAAGCTGCTGCTTCCGGATGACTTTAAGGACTTCAGTCTGCTGTACGAG
  GAGGCGCGCTACTATCAGCTCCAGCCCATGGTGCGCGAGCTGGAGCGCTGGCAGCAGGAG
  CAGGAGCAGCGGCGCCGCAGCCGGGCCTGTGACTGCCTGGTGGTGCGCGTCACGCCCGAC
  TTGGGCGAGCGGATCGCACTCAGCGGCGAGAAGGCCCTCATCGAGGAGGTCTTCCCCGAG
  ACCGGAGACGTCATGTGCAACTCCGTCAACGCCGGCTGGAACCAGGACCCCACGCACGTC
  ATCCGCTTCCCGCTCAATGGCTACTGCCGGCTCAACTCGGTACAGGATGTTCTATAAAAA
  TGGCCCAGAGTATTTTCAACAAAGCGTGCTTCATTTGACACCCAGAGTCTGACTTTGGAT
  TCGAACTAAACCCAGGCAACAGGCGAGGCAGGACAGAGGCTGAGTGGAAAGGTGGTCTGG
  AGCCCCTTCCCTCTCCCTGCTGACCTTGGAGTCGCAGGCACCCACCAGCTGCCAAGAGAA
  TCCCTGGACCGGCTCTTCCTGGATGGGTCCAAGAATTGGACAGCTCAGATGGAGTGAGGG
  CCTATTTTCCAACAGCTCTTCGCAGACCCAAGAGCTTGGCACATTTCCGGGTTAGGGTGG
  AATGGGCTTTGCAGGGAAGAGGGCCCCCTGTGCACGCATTCCACAGCCTGTCGGTCAGAA
  CTTGCTAGTTGCAGGAGACGGGTGTTACACGCAGTCATCAGACCTCACCCTCACAGAGGC
  ACAAACCCACATAGTTGTGGACGCCTGCAGAGACTCAAATATTGAGAGGACTTCTCCTTT
  TTCTCTCCCTCCAGAGCTCCCACGAGCTGATGCACCCCCAGGCTTCAAACCACCTGGAAT
  GCACAGCTCAGGGAAGCTGGTGGATGCCTAGAGGCTGAAGGACAGGGAACTCTCCATTAT
  TGGGGCAGGACTCAGGGAGGACACTTGGGGCCATGTGTCTGGAGAGAGGGCATAGGTTAC
  ACCCTACAGAATAAAGAAGGGACCCAAAGCCTCTTTTTGCCTCCCGGAATCAAGGCCCTG
  AGGGCAGCAGGATGGTGGCCTGGGTGGGGTCGTCCAACTAGGTTTGCTAACCTGAGGGGT
  CACTGGGCCTGGCCACTTCTGTCCCTCTGGTGGTGGAACCCAGCACGTGGTTCTGTAGGG
  ACCTTTGTCAGTGAGCAAGACTGAGATCGTCACAGGAGAAGGTGCCCTTGCTGGCTGCCC
  CAGCAGGCACCCACCTCCCTGCCAGGCCAAGCCAGGTGTCCTCTTGCAGCTTGGCCTTGA
  TGACCTCTGTTTCTTCCTGGGCAGGTCCTGGAGCGGCTGTTCCAGAGGGGTTTCAGCGTG
  GCTGCGTCCTGTGGGGGCGGTGTGGACTCCTCCCAGTTCAGCGAGTATGTGCTTTGCCGG
  GAGGAGCGGCGGCCGCAGCCCACCCCCACTGCTGTTCGAATCAAGCAGGAACCCCTGGAC
  TAGGCCCTGCTTCAGTGCCCACCTGGGCCCCCCCAGGGACCTGGAAACAGTGCTGGGGAG
  TTCTGCCTGTGTATACTTGGCCGTGGGCATGAGACCGAGGGTGAGGCTGGAGGGTCCAAA
  GCTGGCCCAGCGAGCACCAGGGTCCCAGGTGTCATGGCAACAGAACGTGGGATGCTGGAG
  GCATGCCTGCAGAAGGACTGTTGATGCGACCCAAAGATACAGCGGTGGGATCTCTGCTGC
  CAGCTCTCCCAGCCCCTCAGCTTCGCAGCCTGGCGCAGCATCCTCTGAGGCCCCGGGGCC
  TGTTGGGGCGGGGTTGGAAGAGCCGTCTGCAGCTACTTCAGAGGAGCTGTTTATCCCTCT
  CCACGCGGGGCAGACTCTGGCGGGTCTCCTAGCGTCCGAGAGATGGCTTATTTTTCTACA
  GTATTTAAAATGGATGCAGCCCTAACTGCAAAAGTCAGAGAGGCTGACAAGGACCAATGC
  TTCTTTATCTGGTGCTCAGTTCTCAGTCAGACGTGCAGCATGGCTGCAGGGTGGACCAGC
  TGCCTGGCATTCAGGCCCAGATGCCTGCAGGGCTGGGGCTCTCGGGACAGATGCAGGGAT
  GTGTGCTGCAGGGCTGCTGGGAGGAGAGTGGTGGGGGCCTGAGGGCTGAGTGATTCTGTA
  ACCACCTGAGACCTTCACGTTTGCTGCCGTTGGGGGCTCAGGCTGCACTCCCCGGGTCAC
  CTGACCTGCTGCCCAGGGGCTTCCAGTCCTGTCTGTGTGGACTGGCACCTGGGCTGCTGG
  AGAAGTCTCCTCCCGTTCGGACCAGCCTCAGGGCTGCACGTTACCTCAGGAATGGGCCCC
  ACCATGAAGGGGCCCATCTGTCAGCAGCGTCTTCTAGGTCCCCAGCTCAGGGAGCCATCC
  CCAGCTCCAGTTTTCTCATGCGAATATGCACAGTTTTAATTCACGTTGTTACACTAGCCT
  GCCGATGAGACCCAGACACAGGCAGACCTGGCGCTCTTGACCCCTGATTCCAGTGAGGAC
  TGGCCCTGAGGAGTCCTTGCAGACCTGCTGCCTGCCCCACGACAGGCCCAAAGATGGACC
  CCCCCTGGCCTTGTGACAGCTCCCCAAGTGTTCTCCGGTGGAGAAACTGCAGAGGACTGG
  TGGGCGGGGCTCCCCAGCCATCACCATCCTGTGTACAATGGCTGTAGACTTGTATATGGC
  TCCTTTAATATTGTAAAGATGCTGATGTACAATTGTCGTGCATTTGTGTGAACACATTGC
  GTTCCCAGTCCATGCCATAAATGATGCTCTCAAGCAAAAAAAAAAAAAAAAAA
• Restriction Sites: Please inquire
• ACCN: NM_024076
• OTI Disclaimer: Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
• OTI Annotation: This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
• Product Components: The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
• Reconstitution: 1. Centrifuge at 5,000xg for 5min.
  2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
  3. Close the tube and incubate for 10 minutes at room temperature.
  4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
  5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.

Reference Data

• RefSeq: NM_024076.1, NP_076981.1
• RefSeq Size: 3413 bp
• RefSeq ORF: 705 bp
• Locus ID: 79047
• UniProt ID: Q96SI1
• Cytogenetics: 19q13.11
• Domains: BTB, K_tetra
• Protein Families: Ion Channels: Other
• Gene Summary: During embryonic development, interferes with neural crest formation (By similarity). Inhibits AP2 transcriptional activity by interaction with its activation domain.[UniProtKB/Swiss-Prot Function]
  Transcript Variant: This variant represents the longest transcript yet it encodes the shorter protein (isoform 1). Sequence Note: The RefSeq transcript and protein were derived from transcript and genomic sequence to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.